BioCentury

7:00 AM GMT, Mar 26, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Product Development

Reaching proof of concept

Reaching proof of concept

Obesity
Company Product Description Target/ Mechanism Milestones
Alizyme Cetilistat (ATL-962) Lipase inhibitor Lipase Start Ph III 1H07 (A)
Amylin Pramlintide/leptin Synthetic amylin analog/recombinant leptin Amylin receptor/leptin receptor Ph II data 07

Read the full 367 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.